This was an "open-label" study. This means the participants, researchers, study doctors, and other study staff knew what each participant was taking.

The chart below shows the treatments the researchers planned to study.

Treatment 1: Verinurad as a capsule by mouth
Treatment 2: Verinurad as a capsule by mouth
Treatment 3: Verinurad as a capsule by mouth

Treatment 1: Allopurinol as a tablet by mouth
Treatment 2: Allopurinol as a tablet by mouth
Treatment 3: Allopurinol as a tablet by mouth

Treatment 1: Cyclosporine as a capsule by mouth
Treatment 2: Rifampicin as a tablet by mouth
Treatment 3: Once, at least 2 weeks after Treatment 2

4 | Clinical Study Results